Calian Group (TSE:CGY – Get Free Report) has been given a C$60.00 target price by Ventum Financial in a report released on Wednesday,BayStreet.CA reports. The brokerage currently has a “buy” rating on the stock. Ventum Financial’s target price points to a potential upside of 29.42% from the company’s current price.
A number of other equities analysts also recently issued reports on CGY. Canaccord Genuity Group dropped their price objective on shares of Calian Group from C$75.00 to C$60.00 and set a “buy” rating on the stock in a research note on Thursday, May 22nd. Desjardins decreased their price objective on Calian Group from C$82.00 to C$61.00 and set a “buy” rating for the company in a research note on Thursday, May 22nd. Royal Bank of Canada decreased their price objective on Calian Group from C$60.00 to C$58.00 and set an “outperform” rating for the company in a research note on Thursday, May 22nd. Finally, CIBC decreased their price target on shares of Calian Group from C$63.00 to C$62.00 in a research report on Friday, February 14th. Four research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Buy” and a consensus price target of C$63.43.
Read Our Latest Research Report on CGY
Calian Group Stock Up 1.5%
Insider Buying and Selling at Calian Group
In related news, Senior Officer Kevin Lee Ford purchased 1,000 shares of the firm’s stock in a transaction on Monday, May 26th. The stock was acquired at an average price of C$38.05 per share, with a total value of C$38,050.00. Over the last ninety days, insiders acquired 2,734 shares of company stock worth $107,266. 0.63% of the stock is owned by insiders.
About Calian Group
Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management.
See Also
- Five stocks we like better than Calian Group
- How to Choose Top Rated Stocks
- Ignore the Noise—Samsara Stock Is Still a Strong Buy
- How to Effectively Use the MarketBeat Ratings Screener
- 3 Stocks Set to Double—And There’s Still Time to Buy
- 10 Best Airline Stocks to Buy
- Analysts Can’t Get Enough of These Little-Known Biopharma Stocks
Receive News & Ratings for Calian Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calian Group and related companies with MarketBeat.com's FREE daily email newsletter.